These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 25720150)

  • 1. [Progress in nanobody and its application in diagnosis].
    Kong Q; Yao Y; Chen R; Lu S
    Sheng Wu Gong Cheng Xue Bao; 2014 Sep; 30(9):1351-61. PubMed ID: 25720150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Easily Established and Multifunctional Synthetic Nanobody Libraries as Research Tools.
    Liu B; Yang D
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Basis of Epitope Recognition by Heavy-Chain Camelid Antibodies.
    Zavrtanik U; Lukan J; Loris R; Lah J; Hadži S
    J Mol Biol; 2018 Oct; 430(21):4369-4386. PubMed ID: 30205092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Two-Step Approach for the Design and Generation of Nanobodies.
    Wagner HJ; Wehrle S; Weiss E; Cavallari M; Weber W
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction to heavy chain antibodies and derived Nanobodies.
    Vincke C; Muyldermans S
    Methods Mol Biol; 2012; 911():15-26. PubMed ID: 22886243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of nanobodies in plant science and biotechnology.
    Wang W; Yuan J; Jiang C
    Plant Mol Biol; 2021 Jan; 105(1-2):43-53. PubMed ID: 33037986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A guide to: generation and design of nanobodies.
    Muyldermans S
    FEBS J; 2021 Apr; 288(7):2084-2102. PubMed ID: 32780549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanobodies derived from Camelids represent versatile biomolecules for biomedical applications.
    Yu X; Xu Q; Wu Y; Jiang H; Wei W; Zulipikaer A; Guo Y; Jirimutu ; Chen J
    Biomater Sci; 2020 Jul; 8(13):3559-3573. PubMed ID: 32490444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanobodies: natural single-domain antibodies.
    Muyldermans S
    Annu Rev Biochem; 2013; 82():775-97. PubMed ID: 23495938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application Progress of the Single Domain Antibody in Medicine.
    Tang H; Gao Y; Han J
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applications of Nanobodies.
    Muyldermans S
    Annu Rev Anim Biosci; 2021 Feb; 9():401-421. PubMed ID: 33233943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perspectives for the Development of CD38-Specific Heavy Chain Antibodies as Therapeutics for Multiple Myeloma.
    Bannas P; Koch-Nolte F
    Front Immunol; 2018; 9():2559. PubMed ID: 30459772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection and Characterization of Specific Nanobody Against Human Immunoglobulin G.
    Kazemi-Lomedasht F; Behdani M; Rahimpour A; Habibi-Anbouhi M; Poshang-Bagheri K; Shahbazzadeh D
    Monoclon Antib Immunodiagn Immunother; 2015 Jun; 34(3):201-5. PubMed ID: 26090598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Antibody and Nanobody Tools for P2X7.
    Stähler T; Danquah W; Demeules M; Gondé H; Hardet R; Haag F; Adriouch S; Koch-Nolte F; Menzel S
    Methods Mol Biol; 2022; 2510():99-127. PubMed ID: 35776322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variable fragments of heavy chain antibodies (VHHs): a new magic bullet molecule of medicine?
    Smolarek D; Bertrand O; Czerwinski M
    Postepy Hig Med Dosw (Online); 2012 Jun; 66():348-58. PubMed ID: 22706121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanobody‑horseradish peroxidase and -EGFP fusions as reagents to detect porcine parvovirus in the immunoassays.
    Lu Q; Li X; Zhao J; Zhu J; Luo Y; Duan H; Ji P; Wang K; Liu B; Wang X; Fan W; Sun Y; Zhou EM; Zhao Q
    J Nanobiotechnology; 2020 Jan; 18(1):7. PubMed ID: 31910833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research Progresses and Applications of Fluorescent Protein Antibodies: A Review Focusing on Nanobodies.
    Chen YL; Xie XX; Zhong N; Sun LC; Lin D; Zhang LJ; Weng L; Jin T; Cao MJ
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanobodies: From Serendipitous Discovery of Heavy Chain-Only Antibodies in Camelids to a Wide Range of Useful Applications.
    Ji F; Ren J; Vincke C; Jia L; Muyldermans S
    Methods Mol Biol; 2022; 2446():3-17. PubMed ID: 35157266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and development of single domain antibodies as modules for therapeutics and diagnostics.
    Hoey RJ; Eom H; Horn JR
    Exp Biol Med (Maywood); 2019 Dec; 244(17):1568-1576. PubMed ID: 31594404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanobodies as efficient drug-carriers: Progress and trends in chemotherapy.
    Panikar SS; Banu N; Haramati J; Del Toro-Arreola S; Riera Leal A; Salas P
    J Control Release; 2021 Jun; 334():389-412. PubMed ID: 33964364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.